NCT03091374View on ClinicalTrials.gov

Impact of Recombinant Human Growth Hormone on HIV Persistence

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2021

Study Completion Date

December 31, 2024

Conditions
Human Immunodeficiency VirusGrowth Hormone Treatment
Interventions
DRUG

Somatotropin (Human)

Trial Locations (1)

H4A 3J1

Mcgill University Health Center, Montreal

Sponsors

Collaborators (1)

EMD Serono
All Listed Sponsors
collaborator

EMD Serono

INDUSTRY

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT03091374 - Impact of Recombinant Human Growth Hormone on HIV Persistence | Biotech Hunter | Biotech Hunter